# Lactococcus lactis DRG

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lactococcus-lactis-drg
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-03
**Evidence Score:** 2 / 10
**Category:** Fermented/Probiotic
**Also Known As:** L. lactis DRG, Lactococcus lactis strain DRG, DRG strain, Lactococcus lactis DRG probiotic strain, L. lactis DRG culture

## Overview

Lactococcus lactis DRG is a [probiotic](/ingredients/condition/gut-health) bacterial strain that produces bacteriocins and metabolic byproducts capable of modulating lipid [metabolism](/ingredients/condition/weight-management) and gut microbiota composition. Its primary mechanisms include competitive exclusion of pathogenic bacteria and enzymatic interference with cholesterol absorption and synthesis pathways.

## Health Benefits

• Cholesterol management: Mouse studies showed reduced LDL, VLDL, and triglycerides while increasing HDL levels (preliminary evidence)
• Gut colonization enhancement: Demonstrated improved colonization when combined with inulin [prebiotic](/ingredients/condition/gut-health) in animal models (preliminary evidence)
• Antimicrobial activity: Produces heat-stable bacteriocins with broad-spectrum activity against pathogens (in vitro evidence)
• [Immune modulation](/ingredients/condition/immune-support): Shows immunostimulatory potential based on in vitro studies (preliminary evidence)
• Digestive survival: Exhibits 75.2% survival at pH 5 for 4 hours and tolerance to gastric conditions (in vitro evidence)

## Mechanism of Action

Lactococcus lactis DRG produces bacteriocins — ribosomally synthesized [antimicrobial](/ingredients/condition/immune-support) peptides — that disrupt pathogen cell membrane integrity, contributing to its antimicrobial activity. In lipid [metabolism](/ingredients/condition/weight-management), the strain appears to upregulate bile salt hydrolase (BSH) activity, deconjugating bile acids and reducing cholesterol reabsorption in the enterohepatic circulation, which lowers LDL and VLDL serum levels. When co-administered with inulin, the [prebiotic](/ingredients/condition/gut-health) acts as a selective fermentation substrate that promotes DRG colonization by lowering luminal pH via short-chain fatty acid (SCFA) production, particularly acetate and propionate, creating a favorable niche for strain persistence.

## Clinical Summary

Current evidence for Lactococcus lactis DRG is limited to preclinical animal studies, with no published human randomized controlled trials identified to date. Mouse model studies demonstrated statistically significant reductions in LDL, VLDL, and triglyceride levels alongside increases in HDL cholesterol, though specific percentage changes and sample sizes have not been fully disclosed in available literature. Colonization studies in animal models showed enhanced gut persistence when the strain was paired with inulin [prebiotic](/ingredients/condition/gut-health) supplementation compared to the probiotic alone. The overall evidence is considered preliminary, and extrapolation of these findings to human populations requires validation through well-designed clinical trials.

## Nutritional Profile

Lactococcus lactis DRG is a [probiotic](/ingredients/condition/gut-health) bacterial strain with negligible macronutrient contribution at typical dosing. Bioactive compounds include heat-stable bacteriocins (nisin-type lantibiotics and class II bacteriocins) that function as antimicrobial peptides. The strain produces exopolysaccharides (EPS) which contribute to gut mucosa adhesion and [immunomodulat](/ingredients/condition/immune-support)ion. Cell wall components include lipoteichoic acids and peptidoglycans that act as postbiotic immunostimulants via TLR2/TLR4 receptor pathways. Metabolic byproducts include lactic acid (shifting gut pH to ~4.5–5.5), acetate, and diacetyl, which contribute to pathogen inhibition. The strain may produce B-group vitamins including folate (B9) and riboflavin (B2) during fermentation, a characteristic shared with many Lactococcus strains, though strain-specific quantification for DRG is not yet published. Protein content per colony-forming unit is biologically negligible; functional benefit is activity-based rather than nutrient-density-based. Bioavailability of bacteriocins is primarily local (gastrointestinal lumen) rather than systemic.

## Dosage & Preparation

No clinically studied human dosages are available for Lactococcus lactis DRG. Preclinical studies used live bacterial cultures at concentrations supporting ~10^8 CFU/mL viability. No standardized powder or extract forms have been reported. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Lactococcus lactis species are broadly recognized as GRAS (Generally Recognized As Safe) by the FDA and have a long history of use in fermented dairy production, suggesting a favorable general safety profile. No serious adverse events have been documented specifically for the DRG strain in the available preclinical literature, though gastrointestinal effects such as bloating or mild discomfort are plausible as with any probiotic. Individuals who are immunocompromised, critically ill, or have compromised [gut barrier](/ingredients/condition/gut-health) integrity should exercise caution with probiotic supplementation and consult a physician, as rare cases of bacteremia have been reported with Lactococcus species in vulnerable populations. Pregnancy and lactation safety data specific to the DRG strain is absent; women who are pregnant or breastfeeding should seek medical guidance before use.

## Scientific Research

Current evidence for Lactococcus lactis DRG is limited to preclinical studies, with no human clinical trials, RCTs, or meta-analyses identified. Mouse studies (30-day oral feeding) demonstrated hypocholesterolemic effects and enhanced gut colonization when strains LAB-17 and LAB-B1.1 were administered alone or with inulin (p<0.05 via ANOVA). A rat oral mucosal wound model showed increased body weight but no lesion improvement over 10 days (unpaired t-test, p<0.05).

## Historical & Cultural Context

Lactococcus lactis strains have been traditionally used in fermented dairy products including dadih, cheeses, and sausages for centuries. The bacteria serve primarily as starter cultures in dairy fermentation, with [probiotic](/ingredients/condition/gut-health) properties noted in Thai fermented sausages. No specific traditional medicine system associations have been documented.

## Synergistic Combinations

Inulin ([prebiotic](/ingredients/condition/gut-health) fructooligosaccharide, 3–5g/day) demonstrates the most documented synergy with this strain, as animal model data already shows enhanced gut colonization — inulin provides fermentable substrate that selectively supports Lactococcus growth while simultaneously lowering luminal pH to reinforce the strain's [antimicrobial](/ingredients/condition/immune-support) bacteriocin activity. Berberine pairs synergistically via complementary cholesterol-lowering pathways — berberine inhibits PCSK9 and activates LDL-receptor upregulation while L. lactis DRG reduces cholesterol through bile salt hydrolase (BSH) activity and potential direct bile acid deconjugation, targeting both hepatic and intestinal cholesterol cycling simultaneously. Omega-3 fatty acids (EPA/DHA, 1–2g/day) complement the strain's lipid-modulating effects seen in mouse models by reducing hepatic VLDL synthesis via PPARα activation, creating additive triglyceride reduction alongside the probiotic's gut-mediated lipid effects. Lactobacillus acidophilus stacks well as a co-probiotic, occupying a complementary intestinal niche (small intestine vs. Lactococcus's colonic activity) and producing additional bacteriocins (acidolin, lactacin) for additive broad-spectrum antimicrobial coverage without competitive displacement.

## Frequently Asked Questions

### Does Lactococcus lactis DRG actually lower cholesterol?

Animal studies have shown that Lactococcus lactis DRG supplementation reduced LDL, VLDL, and triglyceride levels while increasing HDL cholesterol in mouse models, likely through upregulation of bile salt hydrolase activity. However, no human clinical trials have confirmed these effects, so the cholesterol-lowering benefit remains preliminary and cannot yet be recommended as a standalone cholesterol management strategy.

### What does DRG stand for in Lactococcus lactis DRG?

DRG is a strain-specific designation assigned to differentiate this particular isolate of Lactococcus lactis from other strains within the same species. Probiotic strains are identified at the species, subspecies, and strain level because different strains — even within the same species — can have distinct functional properties, safety profiles, and efficacy outcomes.

### Should Lactococcus lactis DRG be taken with a prebiotic?

Animal model research suggests that combining Lactococcus lactis DRG with inulin, a soluble prebiotic fiber, significantly enhances the strain's ability to colonize the gut compared to taking it alone. Inulin is fermented by the strain to produce short-chain fatty acids like acetate and propionate, which lower luminal pH and create a more hospitable environment for DRG persistence. While synbiotic pairing appears beneficial based on preclinical data, human trials confirming the optimal prebiotic dose or ratio have not been published.

### Is Lactococcus lactis DRG safe for immunocompromised individuals?

Lactococcus lactis as a species is generally considered safe for healthy adults, but immunocompromised individuals — including those on chemotherapy, organ transplant recipients, or people with HIV — face a small but documented risk of opportunistic bacteremia from probiotic strains. No DRG-specific safety studies in immunocompromised populations have been published, so physicians should evaluate risk versus benefit on an individual basis before recommending this strain to vulnerable patients.

### How does Lactococcus lactis DRG fight harmful bacteria?

Lactococcus lactis DRG produces bacteriocins, which are ribosomally synthesized antimicrobial peptides that target and disrupt the cell membrane integrity of competing or pathogenic bacterial species. This mechanism of competitive exclusion helps reduce pathogen load in the gut environment without the use of conventional antibiotics. The specific bacteriocin subtypes produced by the DRG strain and their minimum inhibitory concentrations against named pathogens have not been fully characterized in published literature.

### What is the difference between Lactococcus lactis DRG and other Lactococcus lactis strains?

Lactococcus lactis DRG is a specific clinical strain selected for its enhanced ability to produce heat-stable bacteriocins with broad-spectrum antimicrobial activity against pathogenic bacteria. While other Lactococcus lactis strains exist, the DRG designation indicates this particular isolate has demonstrated superior cholesterol-reducing properties and gut colonization efficiency in research models, distinguishing it from general dairy-derived Lactococcus lactis cultures.

### How strong is the clinical evidence supporting Lactococcus lactis DRG for human health?

Current evidence for Lactococcus lactis DRG is primarily preliminary, consisting of mouse studies and in vitro research demonstrating cholesterol reduction and antimicrobial properties. Human clinical trials are limited, so while animal model results are promising for lipid management and pathogen inhibition, larger and longer-term studies in people are needed to establish efficacy and optimal dosing protocols.

### Who would benefit most from taking Lactococcus lactis DRG supplements?

Lactococcus lactis DRG may be most relevant for individuals interested in cholesterol management and gut health optimization, particularly those seeking probiotic support for pathogenic bacteria resistance. However, because human evidence remains limited to preliminary studies, it is best suited for those willing to use it as part of a broader wellness strategy rather than as a primary therapeutic intervention, and medical consultation is recommended before use.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*